PHARMACIE BAUTES-ROUX : revenue, balance sheet and financial ratios

PHARMACIE BAUTES-ROUX is a French company founded 12 years ago, specialized in the sector Entreposage et stockage non frigorifique. Based in BEZIERS (34500), this company of category PME shows in 2017 a revenue of 1.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE BAUTES-ROUX (SIREN 801261223)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C N/C N/C 1 440 265 € 1 366 422 €
Net income 217 783 € 175 538 € 261 305 € 266 163 € 173 930 € 207 330 € 152 792 € 194 895 € 159 257 €
EBITDA N/C N/C N/C N/C N/C N/C N/C 278 041 € 277 271 €
Net margin N/C N/C N/C N/C N/C N/C N/C 13.5% 11.7%

Revenue and income statement

In 2024, PHARMACIE BAUTES-ROUX generates positive net income of 218 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 159 k€ -> 218 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

217 783 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 9%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 79%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

8.914%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

79.365%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

37.4%

Solvency indicators evolution
PHARMACIE BAUTES-ROUX

Sector positioning

Debt ratio
8.91 2024
2022
2023
2024
Q1: 0.0
Med: 11.12
Q3: 67.77
Good -7 pts over 3 years

In 2024, the debt ratio of PHARMACIE BAUTES-ROUX (8.91) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
79.36% 2024
2022
2023
2024
Q1: 9.65%
Med: 34.88%
Q3: 62.0%
Excellent +9 pts over 3 years

In 2024, the financial autonomy of PHARMACIE BAUTES-ROUX (79.4%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 231.60. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

231.598

Liquidity indicators evolution
PHARMACIE BAUTES-ROUX

Sector positioning

Liquidity ratio
231.6 2024
2022
2023
2024
Q1: 105.43
Med: 164.12
Q3: 324.56
Good +7 pts over 3 years

In 2024, the liquidity ratio of PHARMACIE BAUTES-ROUX (231.60) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE BAUTES-ROUX

Positioning of PHARMACIE BAUTES-ROUX in its sector

Comparison with sector Entreposage et stockage non frigorifique

Valuation estimate

Based on 77 transactions of similar company sales (all years), the value of PHARMACIE BAUTES-ROUX is estimated at 260 060 € (range 94 576€ - 973 539€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2024
77 tx
94k€ 260k€ 973k€
260 060 € Range: 94 576€ - 973 539€
NAF 5 all-time

Valuation method used

Net Income Multiple
217 783 € × 1.2x = 260 061 €
Range: 94 577€ - 973 539€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 77 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Entreposage et stockage non frigorifique)

Compare PHARMACIE BAUTES-ROUX with other companies in the same sector:

Voir toutes les statistiques du secteur Entreposage et stockage non frigorifique

Frequently asked questions about PHARMACIE BAUTES-ROUX

What is the revenue of PHARMACIE BAUTES-ROUX ?

The revenue of PHARMACIE BAUTES-ROUX in 2017 is 1.4 M€.

Is PHARMACIE BAUTES-ROUX profitable?

Yes, PHARMACIE BAUTES-ROUX generated a net profit of 218 k€ in 2024.

Where is the headquarters of PHARMACIE BAUTES-ROUX ?

The headquarters of PHARMACIE BAUTES-ROUX is located in BEZIERS (34500), in the department Herault.

Where to find the tax return of PHARMACIE BAUTES-ROUX ?

The tax return of PHARMACIE BAUTES-ROUX is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE BAUTES-ROUX operate?

PHARMACIE BAUTES-ROUX operates in the sector Entreposage et stockage non frigorifique (NAF code 52.10B). See the 'Sector positioning' section above to compare the company with its competitors.